Polatuzumab Vedotin With R-CHP Shows Strong Activity in Older DLBCL Patients

(MedPage Today) — At the recent American Society of Hematology (ASH) annual meeting, a multicenter retrospective analysis used real-world data to examine the use of polatuzumab vedotin (Polivy) with rituximab, cyclophosphamide, doxorubicin, prednisone…